These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4672886)

  • 1. II. The effects of some hallucinogens on aggressiveness of mice and rats.
    Kostowski W; Rewerski W; Piechocki T
    Pharmacology; 1972; 7(4):259-63. PubMed ID: 4672886
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of isolation-induced attack behavior of mice by drugs.
    Uyeno ET
    J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of some cholinolytic drugs on a number of behavioural parameters measured in the T-maze alternation test: dose-response relationships.
    van der Poel AM
    Psychopharmacologia; 1974 Jun; 37(1):45-58. PubMed ID: 4416217
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids.
    Zetler G; Singbartl G; Schlosser L
    Pharmacology; 1972; 7(4):237-48. PubMed ID: 5077309
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of some hallucinogens on aggressiveness of mice and rats. I.
    Rewerski W; Kostowski W; Piechocki T; Rylski M
    Pharmacology; 1971; 5(5):314-20. PubMed ID: 5104429
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of anticholinergic hallucinogens on spontaneous and conditioned behaviour in rats.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1971; 13(3):195-6. PubMed ID: 5113839
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychoactivity of normacromerine in animals.
    Bourn WM; Keller WJ; Bonfiglio JF
    Life Sci; 1978 Sep; 23(11):1175-84. PubMed ID: 713693
    [No Abstract]   [Full Text] [Related]  

  • 8. Psilocybin: Good Trip or Bad Trip.
    Sellers EM
    Clin Pharmacol Ther; 2017 Oct; 102(4):580-584. PubMed ID: 28548221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].
    Horibe M
    Nihon Yakurigaku Zasshi; 1968 Mar; 64(2):159-85. PubMed ID: 4972692
    [No Abstract]   [Full Text] [Related]  

  • 10. An investigation on the central effects of harmine, harmaline and related beta-carbolines.
    Fuentes JA; Longo VG
    Neuropharmacology; 1971 Jan; 10(1):15-23. PubMed ID: 5569304
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 12. Gas chromatographic determination of ibogaine in biological fluids.
    Cartoni GP; Giarusso A
    J Chromatogr; 1972 Aug; 71(1):154-8. PubMed ID: 5056243
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of benzodiazepines on aggression: reduced or increased?
    DiMascio A
    Psychopharmacologia; 1973 May; 30(2):95-102. PubMed ID: 4576033
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.
    Barrett FS; Johnson MW; Griffiths RR
    J Psychopharmacol; 2015 Nov; 29(11):1182-90. PubMed ID: 26442957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neuroleptics on aggressive behavior.
    Barkov NK
    Neurosci Behav Physiol; 1973; 6(2):119-21. PubMed ID: 4200667
    [No Abstract]   [Full Text] [Related]  

  • 16. High dose psilocybin is associated with positive subjective effects in healthy volunteers.
    Nicholas CR; Henriquez KM; Gassman MC; Cooper KM; Muller D; Hetzel S; Brown RT; Cozzi NV; Thomas C; Hutson PR
    J Psychopharmacol; 2018 Jul; 32(7):770-778. PubMed ID: 29945469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection.
    Villablanca J; Riobó F
    Psychopharmacologia; 1970; 17(4):302-13. PubMed ID: 4331726
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of tremor induction by harmine.
    Kelly DM; Naylor RJ
    Eur J Pharmacol; 1974 Jun; 27(1):14-24. PubMed ID: 4277567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Halluciogenic substances and sleep mechanisms].
    Rougeul A; Verdeaux J
    Rev Can Biol; 1972; 31():Suppl:49-58. PubMed ID: 4538208
    [No Abstract]   [Full Text] [Related]  

  • 20. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.
    Griffiths RR; Johnson MW; Richards WA; Richards BD; McCann U; Jesse R
    Psychopharmacology (Berl); 2011 Dec; 218(4):649-65. PubMed ID: 21674151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.